At a laboratory in Cameroon, technicians receive sputum samples from people suspected of having tuberculosis (TB). Until recently, each person’s sample required a separate test cartridge to detect the bacteria that causes TB. But when cartridges become scarce, the country’s National TB Program found a way to make existing resources go further: testing samples from […] Continue reading ->
November’s US midterm elections swept Democrats into power in both the House and Senate, marking a shift in congressional leadership on key health policies. This comes as a former Trump administration official and a founder of the “Make America Healthy Again” (MAHA) movement accused the administration of catering to industry interests over the health of […] Continue reading ->
Multilateral development banks (MDBs) are moving to centre stage in global health financing, driven by collapsing bilateral aid and political momentum from initiatives like the Accra Reset. Experts see the shift as an opportunity to deliver the predictable, large-scale investment needed to strengthen domestic health systems, provided governments and lenders can ensure transparent terms that […] Continue reading ->
WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence “within three to four weeks” – as soon as DRC regulators issue their own approval, said WHO’s Science Director Meg Doherty, at a Wednesday […] Continue reading ->
The US Food and Drug Administration (FDA) has approved the first generic version of lenacapavir, the highly effective twice-yearly injection to prevent HIV, developed by Dr Reddy’s Laboratories based in India. Dr Reddy’s was one of six pharmaceutical manufacturers that was granted a non-exclusive, royalty-free voluntary licensing agreement from Gilead, which developed lenacapavir. The agreement, […] Continue reading ->
Returning to lead the Global Fund, Mark Dybul argues that the future of global health lies with domestic health systems, not agency mergers in Geneva. Evoking the founding ambition of the early 2000s, the incoming executive director explains how the Accra Reset and US bilateral aid can align under unified national plans – and how […] Continue reading ->
The World Health Organization (WHO) declared mpox a public health emergency of international concern (PHEIC), its highest alarm level, twice within two years, in 2022 and 2024. But “preventable health emergencies are a sign of failure”, said Helen Clark, co-chair of the Independent Panel for Pandemic Preparedness and Response. “They happen when community health care […] Continue reading ->
Action is lagging far behind the milestone commitments of the 2024 UN High Level Declaration on Antimicrobial Resistance (AMR). But a Ministerial Meeting scheduled for 6-8 December in Abuja offers an opportunity to pick up the baton. Ahead of that, civil society gropus will convene in mid-November in Rome. Two years after the UN General […] Continue reading ->
A decade after the Paris Agreement took effect, climate-related heat, drought, floods, disease and dirty air are killing millions. The authors of a major annual report want the World Health Organization (WHO) to classify the crisis as a health emergency. Climate change has become a global health emergency that needs a new WHO instrument to […] Continue reading ->
Former Global Fund executive director Mark Dybul returns to the helm in Geneva, facing an unprecedented $5.32 billion funding gap, fraught domestic transitions, and mounting demands to overhaul the global health architecture. While experts welcome his track record, balancing transatlantic rivalries with rising country sovereignty will demand delicate diplomacy and an updated playbook. The board […] Continue reading ->